keyword
https://read.qxmd.com/read/38479453/selection-of-positive-controls-and-their-impact-on-anti-drug-antibody-assay-performance
#1
JOURNAL ARTICLE
Joshua A Weiner, Harini Natarajan, Calum J McIntosh, Eun Sung Yang, Misook Choe, Cassidy L Papia, Katherine S Axelrod, Gabriela Kovacikova, Amarendra Pegu, Margaret E Ackerman
Development of assays to reliably identify and characterize anti-drug antibodies (ADAs) depends on positive control anti-idiotype (anti-id) reagents, which are used to demonstrate that the standards recommended by regulatory authorities are met. This work employs a set of therapeutic antibodies under clinical development and their corresponding anti-ids to investigate how different positive control reagent properties impact ADA assay development. Positive controls exhibited different response profiles and apparent assay analytical sensitivity values depending on assay format...
March 11, 2024: Journal of Immunological Methods
https://read.qxmd.com/read/38422982/dynamic-establishment-of-recipient-resident-memory-t-cell-repertoire-after-human-intestinal-transplantation
#2
JOURNAL ARTICLE
Wenyu Jiao, Mercedes Martinez, Constanza Bay Muntnich, Julien Zuber, Christopher Parks, Aleksandar Obradovic, Guangyao Tian, Zicheng Wang, Katherine D Long, Elizabeth Waffarn, Kristjana Frangaj, Rebecca Jones, Alaka Gorur, Brittany Shonts, Kortney Rogers, Guoyue Lv, Monica Velasco, Shilpa Ravella, Joshua Weiner, Tomoaki Kato, Yufeng Shen, Jianing Fu, Megan Sykes
BACKGROUND: Understanding formation of the human tissue resident memory T cell (TRM) repertoire requires longitudinal access to human non-lymphoid tissues. METHODS: By applying flow cytometry and next generation sequencing to serial blood, lymphoid tissue, and gut samples from 16 intestinal transplantation (ITx) patients, we assessed the origin, distribution, and specificity of human TRMs at phenotypic and clonal levels. FINDINGS: Donor age ≥1 year and blood T cell macrochimerism (peak level ≥4%) were associated with delayed establishment of stable recipient TRM repertoires in the transplanted ileum...
February 28, 2024: EBioMedicine
https://read.qxmd.com/read/38081407/application-of-enzyme-linked-immunosorbent-assay-to-detect-antimicrobial-peptides-in-human-intestinal-lumen
#3
JOURNAL ARTICLE
Julie S Hong, Abrar Shamim, Hussein Atta, Eric B Nonnecke, Sarah Merl, Satyajit Patwardhan, Elin Manell, Esad Gunes, Philip Jordache, Bryan Chen, Wuyuan Lu, Bo Shen, Beatrice Dionigi, Ravi P Kiran, Megan Sykes, Emmanuel Zorn, Charles L Bevins, Joshua Weiner
Intestinal transplantation is the definitive treatment for intestinal failure. However, tissue rejection and graft-versus-host disease are relatively common complications, necessitating aggressive immunosuppression that can itself pose further complications. Tracking intraluminal markers in ileal effluent from standard ileostomies may present a noninvasive and sensitive way to detect developing pathology within the intestinal graft. This would be an improvement compared to current assessments, which are limited by poor sensitivity and specificity, contributing to under or over-immunosuppression, respectively, and by the need for invasive biopsies...
December 9, 2023: Journal of Immunological Methods
https://read.qxmd.com/read/37838332/extracellular-matrix-remodeling-in-atopic-dermatitis-harnesses-the-onset-of-an-asthmatic-phenotype-and-is-a-potential-contributor-to-the-atopic-march
#4
JOURNAL ARTICLE
Patrick Graff, Dana Woerz, Jenny Wilzopolski, Anne Voss, Jana Sarrazin, Travis M Blimkie, January Weiner, Olivia Kershaw, Preety Panwar, Tillie Hackett, Susanne Lau, Dieter Brömme, Dieter Beule, Young-Ae Lee, Robert E W Hancock, Achim D Gruber, Wolfgang Bäumer, Sarah Hedtrich
The development of atopic dermatitis (AD) in infancy, and subsequent allergies such as asthma in later childhood, is known as the atopic march. The mechanism is largely unknown, yet the course of disease indicates an inter-epithelial crosstalk, through the onset of inflammation in the skin and progression to another mucosal epithelium. Here, we investigated if and how skin-lung epithelial crosstalk contributes to the development of the atopic march. First, we emulated inter-epithelial crosstalk through indirect co-culture of bioengineered atopic-like skin disease models and three-dimensional bronchial epithelial models triggering an asthma-like phenotype in the latter...
October 12, 2023: Journal of Investigative Dermatology
https://read.qxmd.com/read/37802566/safety-tolerability-pharmacokinetics-and-immunological-activity-of-dual-combinations-and-triple-combinations-of-anti-hiv-monoclonal-antibodies-pgt121-pgdm1400-10-1074-and-vrc07-523ls-administered-intravenously-to-hiv-uninfected-adults-a-phase-1-randomised-trial
#5
JOURNAL ARTICLE
Magdalena E Sobieszczyk, Sharon Mannheimer, Carmen A Paez, Chenchen Yu, Theresa Gamble, Deborah A Theodore, Wairimu Chege, Margaret Yacovone, Brett Hanscom, Jack Heptinstall, Kelly E Seaton, Lily Zhang, Maurine D Miner, Amanda Eaton, Joshua A Weiner, Kenneth Mayer, Spyros Kalams, Kathryn Stephenson, Boris Julg, Marina Caskey, Michel Nussenzweig, Lucio Gama, Dan H Barouch, Margaret E Ackerman, Georgia D Tomaras, Yunda Huang, David Montefiori
BACKGROUND: Preclinical and clinical studies suggest that combinations of broadly neutralising antibodies (bnAbs) targeting different HIV envelope epitopes might be required for sufficient prevention of infection. We aimed to evaluate the dual and triple anti-HIV bnAb combinations of PGDM1400 (V2 Apex), PGT121 (V3 glycan), 10-1074 (V3 glycan), and VRC07-523LS (CD4 binding site). METHODS: In this phase 1 trial (HVTN 130/HPTN 089), adults without HIV were randomly assigned (1:1:1) to three dual-bnAb treatment groups simultaneously, or the triple-bnAb group, receiving 20 mg/kg of each antibody administered intravenously at four centres in the USA...
October 2023: Lancet HIV
https://read.qxmd.com/read/37597727/milkshake-western-blot-and-sundae-elisa-we-all-scream-for-better-antibody-validation
#6
JOURNAL ARTICLE
Qiana Mendez, Holland A Driscoll, Gregory R Mirando, Felicity Acca, Cassandra D Chapados, Kezzia S Jones, Michael Weiner, Xiaofeng Li, Mary R Ferguson
Knowing that an antibody's sensitivity and specificity is accurate is crucial for reliable data collection. This certainty is especially difficult to achieve for antibodies (Abs) which bind post-translationally modified proteins. Here we describe two validation methods using surrogate proteins in western blot and ELISA. The first method, which we termed "MILKSHAKE" is a modified maltose binding protein, hence the name, that is enzymatically conjugated to a peptide from the chosen target which is either modified or non-modified at the residue of interest...
August 17, 2023: Journal of Immunological Methods
https://read.qxmd.com/read/37414379/clinical-validation-of-a-multi-protein-serum-based-assay-for-disease-activity-assessments-in-multiple-sclerosis
#7
JOURNAL ARTICLE
Tanuja Chitnis, John Foley, Carolina Ionete, Nabil K El Ayoubi, Shrishti Saxena, Patricia Gaitan-Walsh, Hrishikesh Lokhande, Anu Paul, Fermisk Saleh, Howard Weiner, Ferhan Qureshi, Michael J Becich, Fatima Rubio da Costa, Victor M Gehman, Fujun Zhang, Anisha Keshavan, Kian Jalaleddini, Ati Ghoreyshi, Samia J Khoury
An 18-protein multiple sclerosis (MS) disease activity (DA) test was validated based on associations between algorithm scores and clinical/radiographic assessments (N = 614 serum samples; Train [n = 426; algorithm development] and Test [n = 188; evaluation] subsets). The multi-protein model was trained based on presence/absence of gadolinium-positive (Gd+) lesions and was also strongly associated with new/enlarging T2 lesions, and active versus stable disease (composite of radiographic and clinical evidence of DA) with improved performance (p < 0...
July 4, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37300931/pharmacokinetic-serum-concentrations-of-vrc01-correlate-with-prevention-of-hiv-1-acquisition
#8
JOURNAL ARTICLE
Kelly E Seaton, Yunda Huang, Shelly Karuna, Jack R Heptinstall, Caroline Brackett, Kelvin Chiong, Lily Zhang, Nicole L Yates, Mark Sampson, Erika Rudnicki, Michal Juraska, Allan C deCamp, Paul T Edlefsen, James I Mullins, Carolyn Williamson, Raabya Rossenkhan, Elena E Giorgi, Avi Kenny, Heather Angier, April Randhawa, Joshua A Weiner, Michelle Rojas, Marcella Sarzotti-Kelsoe, Lu Zhang, Sheetal Sawant, Margaret E Ackerman, Adrian B McDermott, John R Mascola, John Hural, M Julianna McElrath, Philip Andrew, Jose A Hidalgo, Jesse Clark, Fatima Laher, Catherine Orrell, Ian Frank, Pedro Gonzales, Srilatha Edupuganti, Nyaradzo Mgodi, Lawrence Corey, Lynn Morris, David Montefiori, Myron S Cohen, Peter B Gilbert, Georgia D Tomaras
BACKGROUND: The phase 2b proof-of-concept Antibody Mediated Prevention (AMP) trials showed that VRC01, an anti-HIV-1 broadly neutralising antibody (bnAb), prevented acquisition of HIV-1 sensitive to VRC01. To inform future study design and dosing regimen selection of candidate bnAbs, we investigated the association of VRC01 serum concentration with HIV-1 acquisition using AMP trial data. METHODS: The case-control sample included 107 VRC01 recipients who acquired HIV-1 and 82 VRC01 recipients who remained without HIV-1 during the study...
June 8, 2023: EBioMedicine
https://read.qxmd.com/read/35931085/dual-ontogeny-of-disease-associated-microglia-and-disease-inflammatory-macrophages-in-aging-and-neurodegeneration
#9
JOURNAL ARTICLE
Aymeric Silvin, Stefan Uderhardt, Cecile Piot, Sandro Da Mesquita, Katharine Yang, Laufey Geirsdottir, Kevin Mulder, David Eyal, Zhaoyuan Liu, Cecile Bridlance, Morgane Sonia Thion, Xiao Meng Zhang, Wan Ting Kong, Marc Deloger, Vasco Fontes, Assaf Weiner, Rachel Ee, Regine Dress, Jing Wen Hang, Akhila Balachander, Svetoslav Chakarov, Benoit Malleret, Garett Dunsmore, Olivier Cexus, Jinmiao Chen, Sonia Garel, Charles Antoine Dutertre, Ido Amit, Jonathan Kipnis, Florent Ginhoux
Brain macrophage populations include parenchymal microglia, border-associated macrophages, and recruited monocyte-derived cells; together, they control brain development and homeostasis but are also implicated in aging pathogenesis and neurodegeneration. The phenotypes, localization, and functions of each population in different contexts have yet to be resolved. We generated a murine brain myeloid scRNA-seq integration to systematically delineate brain macrophage populations. We show that the previously identified disease-associated microglia (DAM) population detected in murine Alzheimer's disease models actually comprises two ontogenetically and functionally distinct cell lineages: embryonically derived triggering receptor expressed on myeloid cells 2 (TREM2)-dependent DAM expressing a neuroprotective signature and monocyte-derived TREM2-expressing disease inflammatory macrophages (DIMs) accumulating in the brain during aging...
August 4, 2022: Immunity
https://read.qxmd.com/read/35750334/improved-durability-to-sars-cov-2-vaccine-immunity-following-coimmunization-with-molecular-adjuvant-adenosine-deaminase-1
#10
JOURNAL ARTICLE
Gina M Cusimano, Ebony N Gary, Matthew R Bell, Bryce M Warner, Jennifer Connors, Nicholas J Tursi, Ali R Ali, Shiyu Zhang, Gabriela Canziani, Bhavani Taramangalam, Emma A Gordon, Irwin M Chaiken, Sarah K Wootton, Trevor Smith, Stephanie Ramos, Darwyn Kobasa, David B Weiner, Michele A Kutzler, Elias K Haddad
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have demonstrated strong immunogenicity and protection against severe disease, concerns about the duration and breadth of these responses remain. In this study, we show that codelivery of plasmid-encoded adenosine deaminase-1 (pADA) with SARS-CoV-2 spike glycoprotein DNA enhances immune memory and durability in vivo. Coimmunized mice displayed increased spike-specific IgG of higher affinity and neutralizing capacity as compared with plasmid-encoded spike-only-immunized animals...
June 24, 2022: Journal of Immunology
https://read.qxmd.com/read/35395272/oral-tolerance-an-updated-review
#11
REVIEW
Rafael M Rezende, Howard L Weiner
Oral tolerance (OT) has classically been defined as the specific suppression of cellular and/or humoral immune responses to an antigen by prior administration of the antigen through the oral route. Multiple mechanisms have been proposed to explain the induction of OT including T cell clonal depletion and anergy when high doses of antigens are fed, and regulatory T (Treg) cell generation following oral administration of low and repeated doses of antigens. Oral antigen administration suppresses the immune response in several animal models of autoimmune disease, including experimental autoimmune encephalomyelitis, uveitis, thyroiditis, myasthenia, arthritis and diabetes, but also non-autoimmune inflammatory conditions such as asthma, atherosclerosis, graft rejection, allergy and stroke...
May 2022: Immunology Letters
https://read.qxmd.com/read/34747368/il-6-receptor-blockade-does-not-slow-%C3%AE-cell-loss-in-new-onset-type-1-diabetes
#12
JOURNAL ARTICLE
Carla J Greenbaum, Elisavet Serti, Katharina Lambert, Lia J Weiner, Sai Kanaparthi, Sandra Lord, Stephen E Gitelman, Darrell M Wilson, Jason L Gaglia, Kurt J Griffin, William E Russell, Philip Raskin, Antoinette Moran, Steven M Willi, Eva Tsalikian, Linda A DiMeglio, Kevan C Herold, Wayne V Moore, Robin Goland, Mark Harris, Maria E Craig, Desmond A Schatz, David A Baidal, Henry Rodriguez, Kristina M Utzschneider, Hendrik J Nel, Carol L Soppe, Karen D Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S Alice Long, Ranjeny Thomas, James G McNamara, Jane H Buckner, Srinath Sanda
BackgroundIL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of residual β cell function in newly diagnosed type 1 diabetes patients.MethodsWe conducted a multicenter, randomized, placebo-controlled, double-blind trial with tocilizumab in new-onset type 1 diabetes. Participants were screened within 100 days of diagnosis. Eligible participants were randomized 2:1 to receive 7 monthly doses of tocilizumab or placebo...
November 8, 2021: JCI Insight
https://read.qxmd.com/read/32437332/robust-antibody-and-cellular-responses-induced-by-dna-only-vaccination-for-hiv
#13
JOURNAL ARTICLE
Stephen DeRosa, Srilatha Edupuganti, Yunda Huang, Xue Han, Marnie Elizaga, Edith Swann, Laura Polakowski, Spyros A Kalams, Michael C Keefer, Janine Maenza, Yiwen Lu, Megan C Wise, Jian Yan, Matthew P Morrow, Amir S Khan, Jean Boyer, Laurent M Humeau, Scott White, Michael N Pensiero, Niranjan Y Sardesai, Mark Bagarazzi, David B Weiner, Guido Ferrari, Georgia Tomaras, David Montefiori, Lawrence Corey, M Juliana McElrath
BACKGROUND: HVTN 098, a randomized, double-blind, placebo-controlled trial, evaluated the safety, tolerability and immunogenicity of PENNVAX®-GP HIV DNA vaccine, administered with or without plasmid IL-12 (pIL-12), via intradermal (ID) or intramuscular (IM) electroporation (EP) in healthy, HIV-uninfected adults. The study tested whether PENNVAX®-GP delivered via ID/EP at 1/5th the dose could elicit equivalent immune responses to delivery via IM/EP, and if inclusion of pIL-12 provided additional benefit...
May 21, 2020: JCI Insight
https://read.qxmd.com/read/30563943/food-allergies-are-associated-with-increased-disease-activity-in-multiple-sclerosis
#14
JOURNAL ARTICLE
Rami Fakih, Camilo Diaz-Cruz, Alicia S Chua, Cindy Gonzalez, Brian C Healy, Neda Sattarnezhad, Bonnie I Glanz, Howard L Weiner, Tanuja Chitnis
OBJECTIVE: The association between allergy and multiple sclerosis (MS) is still unclear. In our study, we assessed the association between a self-reported history of allergic conditions with MS clinical and MRI disease activity. METHODS: A subset of 1349 patients enrolled in the Comprehensive Longitudinal Investigation of Multiple Sclerosis at the Brigham and Women's Hospital (CLIMB) study completed a self-administered questionnaire on environmental, food and drug allergies...
December 18, 2018: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/30004858/cellular-components-and-mechanisms-of-oral-tolerance-induction
#15
JOURNAL ARTICLE
Rafael M Rezende, Howard L Weiner
Oral tolerance can be defined as an inhibition of specific immune responsiveness to subsequent parenteral injections of proteins to which an individual or animal has been previously exposed via the oral route. Multiple mechanisms of tolerance are induced by oral-fed antigens, but induction of regulatory CD4 T-cells expressing the transcription factor Foxp3 and the membrane-bound TGF-β stands out as the major players in oral tolerance. Oral antigen administration suppresses several animal models of autoimmune disease, including experimental autoimmune encephalomyelitis, uveitis, thyroiditis, myasthenia, arthritis, and diabetes, but also nonautoimmune inflammatory conditions such as asthma, atherosclerosis, graft rejection, allergy, and stroke...
2018: Critical Reviews in Immunology
https://read.qxmd.com/read/29162786/are-there-early-signs-that-predict-development-of-temporomandibular-joint-disease
#16
JOURNAL ARTICLE
Adrian Salinas Fredricson, Farid Khodabandehlou, Carina Krüger Weiner, Aron Naimi-Akbar, Johanna Adami, Annika Rosén
Temporomandibular joint disorders (TMJD) involve orofacial pain and functional limitations that may limit important daily activities such as chewing and speaking. This observational case-control study attempted to identify factors associated with TMJD development, particularly inflammation. The study participants were patients treated at Karolinska University Hospital, Stockholm, Sweden. The cases were patients who received a diagnosis of TMJD, chronic closed lock, or painful clicking and were treated surgically during the period from 2007 through 2011...
June 20, 2018: Journal of Oral Science
https://read.qxmd.com/read/25738669/valganciclovir-for-symptomatic-congenital-cytomegalovirus-disease
#17
RANDOMIZED CONTROLLED TRIAL
David W Kimberlin, Penelope M Jester, Pablo J Sánchez, Amina Ahmed, Ravit Arav-Boger, Marian G Michaels, Negar Ashouri, Janet A Englund, Benjamin Estrada, Richard F Jacobs, José R Romero, Sunil K Sood, M Suzanne Whitworth, Mark J Abzug, Mary T Caserta, Sandra Fowler, Jorge Lujan-Zilbermann, Gregory A Storch, Roberta L DeBiasi, Jin-Young Han, April Palmer, Leonard B Weiner, Joseph A Bocchini, Penelope H Dennehy, Adam Finn, Paul D Griffiths, Suzanne Luck, Kathleen Gutierrez, Natasha Halasa, James Homans, Andi L Shane, Michael Sharland, Kari Simonsen, John A Vanchiere, Charles R Woods, Diane L Sabo, Inmaculada Aban, Huichien Kuo, Scott H James, Mark N Prichard, Jill Griffin, Dusty Giles, Edward P Acosta, Richard J Whitley
BACKGROUND: The treatment of symptomatic congenital cytomegalovirus (CMV) disease with intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 months, but the benefits wane over time. METHODS: We conducted a randomized, placebo-controlled trial of valganciclovir therapy in neonates with symptomatic congenital CMV disease, comparing 6 months of therapy with 6 weeks of therapy. The primary end point was the change in hearing in the better ear ("best-ear" hearing) from baseline to 6 months...
March 5, 2015: New England Journal of Medicine
https://read.qxmd.com/read/25638051/characteristics-of-emergency-department-doctor-shoppers
#18
JOURNAL ARTICLE
Scott G Weiner, Christopher A Griggs, Breanne K Langlois, Patricia M Mitchell, Kerrie P Nelson, Franklin D Friedman, James A Feldman
BACKGROUND: There is a need to accurately identify patients at risk for drug abuse before giving a prescription for a scheduled medication. OBJECTIVE: Our aim was to describe a subset of emergency department (ED) patients that had eight or more schedule II-V prescriptions filled from eight or more providers in 1 year, known as "doctor-shopping" (DS) behavior, to compare demographic features of DS and non-DS patients, and to determine clinical factors associated with DS...
April 2015: Journal of Emergency Medicine
https://read.qxmd.com/read/24668841/applying-human-factors-principles-to-alert-design-increases-efficiency-and-reduces-prescribing-errors-in-a-scenario-based-simulation
#19
JOURNAL ARTICLE
Alissa L Russ, Alan J Zillich, Brittany L Melton, Scott A Russell, Siying Chen, Jeffrey R Spina, Michael Weiner, Elizabette G Johnson, Joanne K Daggy, M Sue McManus, Jason M Hawsey, Anthony G Puleo, Bradley N Doebbeling, Jason J Saleem
OBJECTIVE: To apply human factors engineering principles to improve alert interface design. We hypothesized that incorporating human factors principles into alerts would improve usability, reduce workload for prescribers, and reduce prescribing errors. MATERIALS AND METHODS: We performed a scenario-based simulation study using a counterbalanced, crossover design with 20 Veterans Affairs prescribers to compare original versus redesigned alerts. We redesigned drug-allergy, drug-drug interaction, and drug-disease alerts based upon human factors principles...
October 2014: Journal of the American Medical Informatics Association: JAMIA
https://read.qxmd.com/read/22930159/medical-causation-and-expert-testimony-allergists-at-this-intersection-of-medicine-and-law
#20
REVIEW
Howard M Weiner, Ronald E Gots, Robert P Hein
Clinical practice always necessitates proper diagnosis and correct treatment. For most clinical fields, determining the cause of the illness is irrelevant to the intervention. An oncologist, for example, has no need to explore the "cause" of the patient's lymphoma. Allergists, by contrast, have tools and the need to examine the relevant allergen which is the putative "cause" of the patient's allergic symptomatology. In the context of a legal claim, the "cause" of the symptoms or disorder is central, because it determines financial responsibility...
December 2012: Current Allergy and Asthma Reports
keyword
keyword
85383
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.